Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enhanced SUMOylation in polyglutamine diseases.

Hiroko Ueda1, Jun Goto, Hideji Hashida

  • 1Department of Molecular Therapeutics, Tokyo Metropolitan, Institute for Neuroscience, 2-6, Musashi-dai, Fuchu, Tokyo 183-8526, Japan.

Biochemical and Biophysical Research Communications
|June 11, 2002
PubMed
Summary

Small ubiquitin-like modifiers (SUMOs) activate in polyglutamine diseases, including DRPLA, SCA1, MJD, and Huntington's disease. This SUMO-1 system activation suggests its involvement in the neurological pathology of these conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Image Quality Advancements in Low-Dose Pediatric CT Using Super-Resolution Deep-Learning Reconstruction.

Journal of imaging informatics in medicine·2026
Same author

Transcriptomic data and biomedical literature synergize in finding pharmacologic gene regulators.

bioRxiv : the preprint server for biology·2026
Same author

Biallelic variants in FAT3 cause axonal neuropathy with multisystem neurodevelopmental features.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Direct Carotid Artery Exposure for Mechanical Thrombectomy in a Patient with Marfan Syndrome and Prior Total Arch Replacement.

NMC case report journal·2026
Same author

Modulating alternative splicing of <i>MECP2</i> is a potential therapeutic strategy for Rett syndrome.

Science translational medicine·2026
Same author

Direct Pathway Synthesis and Editing (DiPaSE): A One-Pot DNA Assembly Method for Accurate and Efficient Refactoring of High-GC Biosynthetic Gene Clusters.

ACS synthetic biology·2026

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Small ubiquitin-like modifiers (SUMOs) are critical for regulating protein localization and transport within the nucleus.
  • Dysregulation of protein homeostasis is implicated in various neurodegenerative disorders.

Purpose of the Study:

  • To investigate the role of SUMO-1 in polyglutamine-repeat diseases such as DRPLA, SCA1, MJD, and Huntington's disease.
  • To determine if SUMOylation pathways are altered in affected brain regions.

Main Methods:

  • Immunohistochemistry on brain tissue from patients with DRPLA, SCA1, MJD, and Huntington's disease.
  • Western blot analysis of cerebellar cortex from a transgenic mouse model expressing mutant ataxin-1.

Main Results:

Related Experiment Videos

  • Neurons in affected brain regions of polyglutamine disease patients showed a strong reaction to SUMO-1.
  • Increased levels of SUMOylated proteins (termed ESCA1 and ESCA2) were observed in the cerebellar cortex of mutant ataxin-1 mice.

Conclusions:

  • The SUMO-1 system is activated in polyglutamine diseases.
  • SUMO-1 activation is likely implicated in the pathological mechanisms underlying these neurodegenerative conditions.